SWITCHING INFLIXIMAB TO SUBCUTANEOUS FROM INTRAVENOUS THERAPY (SWIMSUIT) - A PROSPECTIVE, REAL-WORLD PHASE IV INTERVENTIONAL STUDY

被引：0
|
作者：
Rahmany, Sohail [1 ]
Young, David [1 ]
Moyses, Helen [2 ]
Gonclaves, Joao [3 ]
Latter, Sue [4 ]
Cummings, Fraser [1 ]
机构：
[1] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[2] Southampton Gen Hosp, NIHR Biomed Res Unit, Southampton, Hants, England
[3] Univ Lisbon, IMed Res Inst Med, Dept Pharm, Lisbon, Portugal
[4] Univ Southampton, Sch Hlth Sci, Southampton, Hants, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.152
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P80
引用
收藏
页码：A92 / A93
页数：2
相关论文
共 50 条
  • [31] Assessing real world dose adjustment in patients switching from intravenous immunoglobulin (IGIV) therapy to subcutaneous immunoglobulin (IGSC) 20%.
    Ye, Xiaolan
    Xiong, Yan
    Li-McLeod, Josephine
    PHARMACOTHERAPY, 2014, 34 (10): : E222 - E222
  • [32] Switching from intravenous to subcutaneous infliximab: physicians' practice and patients' satisfaction - Results from a nationwide transectional study
    Hupe, M.
    Laharie, D.
    Wils, P.
    Uzzan, M.
    Peyrin-Biroulet, L.
    Kirchgesner, J.
    Atanasiu, C.
    Cadiot, G.
    Richard, N.
    Simon, M.
    Caillo, L.
    Nancey, S.
    de Maissin, A.
    Vuitton, L.
    Hebuterne, X.
    Alric, H.
    Coffin, B.
    Gellouz, S.
    Buisson, A.
    GETAID
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1280 - i1281
  • [33] Assessing Real World Dose Adjustment in Patients Switching from Intravenous Immunoglobulin (IGIV) Therapy to Subcutaneous Immunoglobulin (IGSC) 20%
    Luo, Michelle
    Iyer, Ravi
    Xiong, Yan
    Li-McLeod, Josephine
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 392 - 392
  • [34] EFFICACY AND SAFETY OF ELECTIVE SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A MULTI-CENTRE COHORT STUDY
    Smith, Philip J.
    Storey, Daniel
    Gregg, Belle
    Critchley, Lisa
    Stenson, June
    Kneebone, Andrew
    Rimmer, Tracy
    Burke, Stevena
    Teoh, Wan Yi
    Vazeille, Stephan
    Serna, Solange
    Bond, Ashley
    Steel, Alan
    Dibb, Martyn
    Collins, Paul
    Derbyshire, Edmund
    Bodger, Keith
    Probert, Christopher
    Verma, Ajay
    Subramanian, Sreedhar
    GUT, 2021, 70 : A84 - A84
  • [35] Real-world effectiveness of vedolizumab in managing refractory pouchitis: a multicenter study on intravenous to subcutaneous transition
    Gimeno-Pitarch, L.
    Minguez, A.
    Cespedes, E.
    Ferreiro-Iglesias, R.
    Martin-Arranz, M. D.
    Sicilia, B.
    Lorca, I
    Huguet, J. M.
    Mesonero, F.
    Vicente, R.
    Nos, P.
    Iborra, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1610 - I1611
  • [36] Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study
    Kim, K.
    Hong, S. N.
    Kang, S. B.
    Lee, K. M.
    Koo, J. S.
    Jung, Y.
    Lee, B. J.
    Yoon, H.
    Kim, H. W.
    Lim, Y. J.
    Lee, H. S.
    Lee, Y. J.
    Lee, J.
    Lee, C. K.
    Shin, S. Y.
    Moon, J. M.
    Seo, J.
    Choi, C. H.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1007 - I1009
  • [37] Maven4: Phase IV non interventional, prospective, Spanish multicenter study to evaluate Cladribine tablets long term effectiveness on real-world clinical practice
    Saiz, A.
    Aladro, Y.
    Costa-Frossard, L.
    Sanchez Magro, I.
    Rodriguez-Antiguedad, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 675 - 676
  • [38] Clinical efficacy and durability of subcutaneous infliximab in patients with moderate-to-severe inflammatory bowel disease : a real-world data from a Korean multicentre prospective cohort study
    Kim, K.
    Hong, S. N. H.
    Kang, S. B. K.
    Lee, K. M.
    Koo, J. S. K.
    Jung, Y.
    Lee, B. J. L.
    Yoon, H. Y.
    Kim, H. W.
    Lim, Y. J.
    Lee, H. S.
    Lee, Y. J.
    Lee, J.
    Lee, C. K.
    Moon, J. M.
    Shin, S. Y.
    Seo, J.
    Choi, C. H.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1410 - I1412
  • [39] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study
    Nicodemus Jr, Nemencio
    Ang-Golangco, Nerissa
    Aquitania, Grace
    Ardena, Gregory Joseph Ryan
    Dampil, Oliver Allan
    Fernando, Richard Elwyn
    Flor, Nicole-Therese
    Kho, Sjoberg
    Matawaran, Bien
    Mirasol, Roberto
    Panelo, Araceli
    Pasaporte, Francis
    Puno-Rocamora, Mercerose
    Shoeb, Ahsan
    Tolentino, Marsha
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2024,
  • [40] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes in Malaysia: Results from a Prospective, Non-interventional Real-World Study
    Mohamed, Mafauzy
    Lim, Siang Chin
    Mumtaz, Malik
    Uppal, Shweta
    Mukherjee, Deepak
    Kassim, Mohamed Saiful Mohd
    Sreedharan, Shalini
    Doraiswamy, Amudha Murugan
    Chong, Kuck Meng
    Tat, Lu Yu
    Nordin, Sudzilla Binti
    Giek, Jeshen Lau Hui
    Hussein, Zanariah
    Kadir, Khalid Abdul
    Lau, Bik Kui
    Chan, Siew Pheng
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (01): : 37 - 44
12345